— Know what they know.
Not Investment Advice

ATNX NASDAQ

Athenex, Inc.
1W: -42.1% 1M: -82.5% 3M: -92.8% 1Y: -97.9% 3Y: -99.9% 5Y: -99.9%
$0.20
Last traded 2023-05-24 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $2.3M mcap · 7M float · 3.93% daily turnover

📊 Key Metrics

TTM
$120M
Revenue
-0.3% YoY
$-103M
Net Income
+46.6% YoY
$-77M
Free Cash Flow
+49.4% YoY
27.4%
Gross Margin
-66.7%
Op. Margin
-114.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE22.4%
ROA-43.6%
ROIC6960.0%

Valuation

P/E-0.0
P/B-0.2
EV/EBITDA-0.4

Leverage

Debt/Equity-6.51
Current Ratio1.09
Interest Cov.-2.5x

Quality Scores

Piotroski F6/9
Altman Z-7.29
Beneish M-3.58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms